DATANG POWER (601991.SH) plans to inject RMB 628 million in capital into Datang Nuclear Power Company.
Datang Power (601991.SH) has announced that on October 9, 2026, the company signed a "China Datang Group Nuclear Power Company Capital Increase Agreement" together with China Datang Group Corporation Limited ("Datang Group") and China Datang Group Nuclear Power Company Limited ("Datang Nuclear Power Company"). According to the agreement, Datang Group will contribute RMB 942 million based on its 60% shareholding ratio, and the company will contribute RMB 628 million based on its 40% shareholding ratio, to pay for the basic construction costs of the Liaoning Xudabao Nuclear Power Project and the Fujian Ningde Nuclear Power Phase II Project, the equipment procurement and construction preparation costs for Phase I of the Liaoning Zhuanghe Nuclear Power Project, and the preliminary costs of the Guangdong Yangxi Nuclear Power Project, etc. After the capital increase is completed, the shareholding ratios of all parties in Datang Nuclear Power Company will remain unchanged.
DATANG POWER (601991.SH) announced that on October 9, 2026, the company signed a "China Datang Group Nuclear Power Co., Ltd. Capital Increase Agreement" together with China Datang Group Co., Ltd. ("Datang Group") and China Datang Group Nuclear Power Co., Ltd. ("Datang Nuclear Power Company"). According to the agreement, Datang Group will contribute RMB 942 million based on its 60% shareholding ratio, and the company will contribute RMB 628 million based on its 40% shareholding ratio, to pay for the basic construction costs of the Liaoning Xudabao Nuclear Power Project and the Fujian Ningde Nuclear Power Phase II Project, the equipment procurement and construction preparation costs of the Liaoning Zhuanghe Nuclear Power Project Phase I, and the preliminary costs of the Guangdong Yangxi Nuclear Power Project, etc. After the completion of the capital increase, the shareholding ratios of all parties in Datang Nuclear Power Company will remain unchanged.
Related Articles

ANHUIEXPRESSWAY (00995): Pan Ping Appointed as Independent Non-Executive Director

CIRC (01763): China Isotope & Radiation Corporation's HTA 50mg Urea 13C Breath Test Kit Obtains Drug Registration Certificate

Shenzhen Kinwong Electronic (03228) expects Q3 net profit attributable to shareholders to increase by 205.46% to 264.74% year-on-year.
ANHUIEXPRESSWAY (00995): Pan Ping Appointed as Independent Non-Executive Director

CIRC (01763): China Isotope & Radiation Corporation's HTA 50mg Urea 13C Breath Test Kit Obtains Drug Registration Certificate

Shenzhen Kinwong Electronic (03228) expects Q3 net profit attributable to shareholders to increase by 205.46% to 264.74% year-on-year.






